Assessment of nutritional status in elderly patients with gastroesophageal cancer: A post hoc analysis.

J Jasmeet Kaur V Vanessa Wookey (Fox Chase Cancer Center, Philadelphia, PA) C Caitlin R. Meeker (Fox Chase Cancer Center, Philadelphia, PA) M Meghan Meghan Connors (Fox Chase Cancer Center, Philadelphia, PA) E Elizabeth A. Handorf (Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, NJ) M Mohamedtaki Abdulaziz Tejani (AdventHealth Cancer Institute, Orlando, FL) G Grant Richard Williams (Division of Hematology & Oncology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL) A Arthur Winer (Inova Dwight and Martha Schar Cancer Institute, Fairfax, VA) S Sukeshi Patel Arora (Mays Cancer Center, UT Health San Antonio; MD Anderson Cancer Center, San Antonio, TX) J Juhi Mittal (Fox Chase Cancer Center, Philadelphia, PA) K Kelly A. Filchner (Fox Chase Cancer Center, Philadelphia, PA) N Namrata Vijayvergia (Fox Chase Cancer Center, Philadelphia) E Efrat Dotan (17University of Pennsylvania, Lancaster, United States)

Abstract

389 Background: Elderly patients with gastroesophageal cancer (GEC) frequently suffer from malnutrition due to tumor location and treatment-related toxicity. Malnutrition is associated with increased morbidity and mortality in this population. This study investigates the relationship between body mass index (BMI), Mini Nutritional Assessment (MNA) scores, unintentional weight loss (UWL), and chemotherapy toxicity while identifying key factors influencing nutritional status. Methods: This post hoc analysis utilized data from a prospective, multicenter study of patients aged 65 and older with all stages of GEC undergoing chemotherapy. Nutritional assessments were conducted using validated tools, focusing on BMI, MNA, and UWL over three months post enrollment. We defined malnourished patients as those with abnormal BMI (<18.5 or >30), low MNA (0-11), and significant UWL (≥10%). We analyzed associations between nutritional status and geriatric assessment comorbidities, depression score, functional status, cognition, hospitalization, treatment toxicity, and social support using Fisher’s exact tests. Results: Eighty-two patients were enrolled, with a median age of 73 years (range 65-91 years). The cohort was predominantly male (74%) and primarily presented with stage III-IV disease (82%), most receiving first-line therapy (79%). Primary sites included gastric (32%), esophageal (43%), and gastroesophageal junction (26%). Notably, 34% of patients had abnormal BMI, with 2 patients classified as underweight (BMI <18.5) and 19 as obese (BMI >30). Approximately 69% reported UWL, of 10% or greater. MNA scores indicated malnutrition in about 66% of patients (severe (0-7): 15 patients; moderate (8-11): 37 patients), while 31% scored within the normal range (12-14).Hospital admissions were significantly higher in patients with low MNA (33% vs. 3%; p=0.002) and UWL (29% vs. 8%; p=0.047). No significant correlations were observed between nutritional status and treatment type, treatment toxicity, or other geriatric assessment variables, including functional status and social support. Conclusions: MNA and UWL are effective indicators of nutritional status in elderly GEC patients, while BMI is not a reliable measure. Malnutrition significantly correlates with increased hospital admissions, highlighting the need for reliable tools to measure malnutrition to implement necessary interventions. Further research is required to explore the broader implications of malnutrition on treatment outcomes and quality of life in this vulnerable population.

Article Details

Volume / Issue Vol. 43, Issue 4_suppl
Published February 01, 2025
Pages 389-389
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (13)

J

Jasmeet Kaur

V

Vanessa Wookey

Fox Chase Cancer Center, Philadelphia, PA

C

Caitlin R. Meeker

Fox Chase Cancer Center, Philadelphia, PA

M

Meghan Meghan Connors

Fox Chase Cancer Center, Philadelphia, PA

E

Elizabeth A. Handorf

Department of Biostatistics and Epidemiology, Rutgers School of Public Health, New Brunswick, NJ

M

Mohamedtaki Abdulaziz Tejani

AdventHealth Cancer Institute, Orlando, FL

G

Grant Richard Williams

Division of Hematology & Oncology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL

A

Arthur Winer

Inova Dwight and Martha Schar Cancer Institute, Fairfax, VA

S

Sukeshi Patel Arora

Mays Cancer Center, UT Health San Antonio; MD Anderson Cancer Center, San Antonio, TX

J

Juhi Mittal

Fox Chase Cancer Center, Philadelphia, PA

K

Kelly A. Filchner

Fox Chase Cancer Center, Philadelphia, PA

N

Namrata Vijayvergia

Fox Chase Cancer Center, Philadelphia

E

Efrat Dotan

17University of Pennsylvania, Lancaster, United States